Cellular Senescence
Year: 2026
Type: article
Abstract: Cellular senescence is a state of irreversible cell cycle arrest that serves as a fundamental mechanism in organismal biology, playing paradoxical roles as both a protective tumor-suppressive barrier and a driver of age-related pathology. This review presents a comprehensive analysis of the current state of knowledge regarding cellular senescence, its molecular mechanisms, and the emerging therapeutic landscape of senotherapeutics. We examine: (1) the molecular hallmarks of senescence, including cell cycle arrest pathways (p53/p21 and p16INK4a/RB), the senescence-associated secretory phenotype (SASP), and morphological changes; (2) the dual physiological roles of senescence in embryonic development, wound healing, tumor suppression, and age-related disease; (3) the mechanistic basis of SASP-driven chronic inflammation (“inflammaging”) and its contribution to cardiovascular disease, neurodegeneration, cancer, and metabolic disorders; (4) the current state of senotherapeutic interventions, including first-generation senolytics (dasatinib + quercetin, navitoclax/ABT-263), next-generation precision approaches (immune-based senolysis, PROTACs, CAR-T cells), and senomorphics; and (5) the challenges of senescence heterogeneity, biomarker limitations, and off-target toxicity that must be addressed for successful clinical translation. Based on critical analysis of the literature, we propose a conceptual framework for understanding senescence as a context-dependent, heterogeneous cellular state requiring precision therapeutic approaches rather than blanket elimination.
Source: Annals of Rejuvenation Science
DOI: 10.65649/9t6t6458
Author: Ketevan Lichely
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Keywords: cellular senescence, senotherapeutics, senolytics, senomorphics, senescence-associated secretory phenotype, inflammaging, p53/p21 pathway, tumor suppression, age-related diseases, cardiovascular disease, neurodegeneration, PROTACs, chimeric antigen receptor T cells, senescence heterogeneity, senescence biomarkers, off-target toxicity
Open Access status: hybrid
OpenAlex ID: W7155390876
